Table 3.
Univariatea | Multivariateb | |||
---|---|---|---|---|
| ||||
P-value | HRc | 95% CId | P-value | |
Sex | ||||
Male vs Female | 0.9427 | - | ||
Age | ||||
≥65 vs <65 | 0.7749 | 2.74 | 1.134-6.967 | 0.0250 |
Siewert type | ||||
Type2 vs Type3 | 0.8131 | - | ||
Histological type | ||||
Undiffe. vs Diffe. | 0.0486 | - | ||
Tumor size (mm) | ||||
≥40 vs <40 | 0.0185 | - | ||
Venous invasion | ||||
Positive vs Negative | <0.0001 | - | ||
Lymphatic invastion | ||||
Positive vs Negative | <0.0001 | 5.28 | 1.431-25.51 | 0.0116 |
PT-stage | ||||
T4 vs T1-3 | <0.0001 | 4.74 | 2.004-12.21 | 0.0003 |
PN-stage | ||||
N3 vs N0-2 | <0.0001 | 3.28 | 1.354-8.607 | 0.0081 |
YWHAZ expression | ||||
High vs Low | 0.0108 | 4.49 | 1.736-13.06 | 0.0015 |
Kaplan and Meier method, and the statistical significance was determined by log-rank test;
Multivariate survival analysis was performed using Cox’s proportional hazard model;
HR: hazard ratio;
CI: confidence interval.